- Home
- HQI vs DERM Comparison
HQI vs DERM Comparison
Compare HQI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- DERM
- Stock Information
- Founded
- HQI 2002
- DERM 2014
- Country
- HQI United States
- DERM United States
- Employees
- HQI N/A
- DERM N/A
- Industry
- HQI Professional Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- HQI Consumer Discretionary
- DERM Health Care
- Exchange
- HQI Nasdaq
- DERM Nasdaq
- Market Cap
- HQI 143.3M
- DERM 165.6M
- IPO Year
- HQI N/A
- DERM 2021
- Fundamental
- Price
- HQI $9.94
- DERM $7.21
- Analyst Decision
- HQI Strong Buy
- DERM Strong Buy
- Analyst Count
- HQI 2
- DERM 2
- Target Price
- HQI $16.00
- DERM $10.50
- AVG Volume (30 Days)
- HQI 14.4K
- DERM 112.3K
- Earning Date
- HQI 08-07-2025
- DERM 08-11-2025
- Dividend Yield
- HQI 2.46%
- DERM N/A
- EPS Growth
- HQI N/A
- DERM N/A
- EPS
- HQI 0.24
- DERM N/A
- Revenue
- HQI $33,651,000.00
- DERM $56,243,000.00
- Revenue This Year
- HQI N/A
- DERM $28.99
- Revenue Next Year
- HQI $4.99
- DERM $52.61
- P/E Ratio
- HQI $40.30
- DERM N/A
- Revenue Growth
- HQI N/A
- DERM N/A
- 52 Week Low
- HQI $9.04
- DERM $3.54
- 52 Week High
- HQI $15.75
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- HQI 47.31
- DERM 49.01
- Support Level
- HQI $9.66
- DERM $6.90
- Resistance Level
- HQI $10.13
- DERM $8.09
- Average True Range (ATR)
- HQI 0.41
- DERM 0.36
- MACD
- HQI -0.03
- DERM -0.04
- Stochastic Oscillator
- HQI 32.71
- DERM 26.09
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.